Name: Gregor Leibundgut

Qualification: MD

Country: Germany


Department of Cardiology and Angiology II, 
University Heart Center Freiburg - Bad Krozingen.

Phone no: +41 61 265 5214

Email: Send an Email


Bad Krozingen,

Research Interests:

Heart Failure, Atherosclerosis, Echocardiography, Innate Immunity, Clinical Cardiology, Myocardial Infarction, Cardiovascular Medicine, Cardiology, Chronic Heart Failure, Interventional Cardiology, Lipoproteins, Cardiovascular Disease, Vascular Medicine, Cardiovascular, Coronary Artery Disease.



  1. Predictors of early readmission or death in elderly patients with heart failure.
  2. End stage chronic heart failure.
  3. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: Does stent diameter matter? Three-year follow-up of BASKET.
  4. Oxidized Phospholipids Are Present on Plasminogen, Affect Fibrinolysis, and Increase Following Acute Myocardial Infarction.
  5. Collagen Plug Vascular Closure Devices and Reduced Risk of Bleeding with Bivalirudin Versus Heparin Plus Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Non ST-Segment Elevation Myocardial Infarction.
  6. Percutaneous Retrieval of a Twisted Guide Catheter Using a Longer Second Radial Sheath.
  7. Release and Capture of Bioactive Oxidized Phospholipids and Oxidized Cholesteryl Esters During Percutaneous Coronary and Peripheral Arterial Interventions in Humans.
  8. Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.
  9. NT-proBNP Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations – Results From TIME-CHF.
  10. Cardiovascular Management of Cancer Patients With Chemotherapy-Associated Left Ventricular Systolic Dysfunction in Real-World Clinical Practice.